Boston Scientific Corp. Reaches New 12-Month High at $12.39 (BSX)
Boston Scientific Corp. (NYSE:BSX)’s share price reached a new 52-week high during mid-day trading on Wednesday, AnalystRatings.Net reports. The stock traded as high as $12.39 and last traded at $12.32, with a volume of 9,164,124 shares traded. The stock had previously closed at $12.08.
BSX has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Boston Scientific Corp. in a research note to investors on Wednesday, October 9th. They now have a $12.00 price target on the stock. Separately, analysts at CL King downgraded shares of Boston Scientific Corp. from a “buy” rating to a “neutral” rating in a research note to investors on Tuesday, September 10th. Finally, analysts at Barclays reiterated a “buy” rating on shares of Boston Scientific Corp. in a research note to investors on Wednesday, September 4th. They now have a $12.00 price target on the stock. Fourteen equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Boston Scientific Corp. has an average rating of “Hold” and an average target price of $9.69.
Boston Scientific Corp. has a one year low of $5.04 and a one year high of $12.34. The stock has a 50-day moving average of $11.58 and a 200-day moving average of $9.81. The company’s market cap is $16.584 billion.
Boston Scientific Corp. (NYSE:BSX) last posted its quarterly earnings results on Thursday, July 25th. The company reported $0.18 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.10 by $0.08. The company had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.78 billion. During the same quarter last year, the company posted $0.17 earnings per share. Boston Scientific Corp.’s revenue was down 1.0% compared to the same quarter last year. On average, analysts predict that Boston Scientific Corp. will post $0.44 earnings per share for the current fiscal year.
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.